Novavax (NASDAQ:NVAX) Upgraded at StockNews.com

StockNews.com upgraded shares of Novavax (NASDAQ:NVAX – Free Report) from a sell rating to a hold rating in a research note released on Friday. Separately, HC Wainwright reaffirmed a buy rating and set a $35.00 price target on shares of Novavax in a research note on Thursday, August 10th. Get Our Latest Report on Novavax […]

Leave a Reply

Your email address will not be published.

Previous post TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com
Next post aTyr Pharma (NASDAQ:LIFE) Upgraded at StockNews.com